Collegium Pharmaceutical (COLL) Intangibles (2018 - 2026)

Collegium Pharmaceutical's Intangibles history runs 7 years deep, the most recent figure standing at $614.0 million for Q1 2026.

• In Q1 2026, Intangibles fell 26.54% year-over-year to $614.0 million; the TTM figure through Mar 2026 stood at $614.0 million (down 26.54% YoY), while the FY2025 annual figure was $669.5 million, down 24.89% from the prior year.
• Intangibles was $614.0 million for Q1 2026 at Collegium Pharmaceutical, down from $669.5 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $966.2 million in Q1 2022 to a low of $352.7 million in Q2 2024.
• Historically, Intangibles has averaged $742.1 million across 5 years, with a median of $780.5 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Intangibles plunged 62.92% in 2024, then soared 121.3% in 2025.
• A 5-year view of Intangibles shows it stood at $567.5 million in 2022, then retreated by 25.69% to $421.7 million in 2023, then surged by 111.38% to $891.4 million in 2024, then dropped by 24.89% to $669.5 million in 2025, then dropped by 8.29% to $614.0 million in 2026.
• The last three Intangibles figures came in at $614.0 million (Q1 2026), $669.5 million (Q4 2025), and $725.0 million (Q3 2025), per Business Quant data.